Cargando…

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

BACKGROUND: Pharmacological inhibitors of vascular endothelial growth factor (VEGF) receptors, like vatalanib, have been tested in randomised trials (CONFIRM (Colorectal Oral Novel therapy For the Inhibition of Angiogenesis and Retarding of Metastases) 1 and 2) in colorectal cancer showing activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Gatter, K C, Trarbach, T, Folprecht, G, Shi, M M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461163/ https://www.ncbi.nlm.nih.gov/pubmed/22910317 http://dx.doi.org/10.1038/bjc.2012.369

Ejemplares similares

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))
por: GAUMANN, ANDREAS K.A., et al.
Publicado: (2014)

Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth
por: Hess, C, et al.
Publicado: (2001)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia
por: Koukourakis, M I, et al.
Publicado: (2010)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis
por: Sivridis, E, et al.
Publicado: (2002)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
por: Giatromanolaki, A, et al.
Publicado: (2001)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2003)

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study
por: Joensuu, H, et al.
Publicado: (2011)

Human Papillomavirus in Endometrial Adenocarcinomas: Infectious Agent or a Mere “Passenger”?
por: Giatromanolaki, A., et al.
Publicado: (2007)

Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines
por: Koukourakis, Michael I., et al.
Publicado: (2015)

Angiogenic Factor Expression in Hepatic Cirrhosis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2007)

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer
por: Koukourakis, M I, et al.
Publicado: (2012)

Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer
por: To, Kenneth K.W., et al.
Publicado: (2016)

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy
por: Koukourakis, M I, et al.
Publicado: (2014)

Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism
por: Giatromanolaki, Alexandra, et al.
Publicado: (2017)

Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report
por: Sivridis, Efthimios, et al.
Publicado: (2019)

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
por: Kalaitzis, Christos, et al.
Publicado: (2014)

The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020)

787. Improving ED Sepsis Care
por: Sloan, William A, et al.
Publicado: (2019)

Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.
por: Kaklamanis, L., et al.
Publicado: (1996)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
por: Kakolyris, S, et al.
Publicado: (2000)

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.
por: Koukourakis, M. I., et al.
Publicado: (1997)

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
por: Koukourakis, M. I., et al.
Publicado: (1998)

Exome sequencing and analysis of 454,787 UK Biobank participants
por: Backman, Joshua D., et al.
Publicado: (2021)

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
por: Stupp, R., et al.
Publicado: (2011)

Synthesis of Binderless ZK-4 Zeolite Microspheres at High Temperature
por: Fawaz, Elyssa G., et al.
Publicado: (2018)

p53 and angiogenesis in non-small-cell lung cancer.
por: Giatromanolaki, A., et al.
Publicado: (1998)

Enabling Blockchain Services for IoE with Zk-Rollups
por: Lavaur, Thomas, et al.
Publicado: (2022)

Endometrial Stromal Hyperplasia: An Underrecognized Condition
por: Sivridis, Efthimios, et al.
Publicado: (2013)

Potential inhibitory effects of compounds ZK-PI-5 and ZK-PI-9 on trehalose and chitin metabolism in Spodoptera frugiperda (J. E. Smith)
por: Zhong, Fan, et al.
Publicado: (2023)

Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma
por: Shankar, Adarsh, et al.
Publicado: (2016)

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2021)

Run 787, 76-12-6, High Intensity Stacking and Vacuum Limit in R1
por: Fischer, E, et al.
Publicado: (1976)

run 787 - 26 GeV/c, Linear coupling effects on the effective height
por: Guignard, G
Publicado: (1977)

2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib
por: Gohlke, Bjoern-Oliver, et al.
Publicado: (2015)

Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl(4)-induced fibrotic mice
por: Kong, Ling-Jian, et al.
Publicado: (2017)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aglj1d8l4eeei9b0mvso5nde56